Home / Resources / Publications

出版物

Featured publication

IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia

Recent clinical trial successes in schizophrenia with non-dopaminergic agents have rejuvenated the field after a long period of unsuccessful attempts. At the same time,…

Latest publications

All Publication

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

MIDD in Japan – Implementations, challenges and opportunities

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

Popular publications

All Publication

Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores

在模型引导的药物开发中实施“学习-确认”策略：评估免疫原性定量系统药理学平台

针对复发难治性（R/R）骨髓纤维化（MF）及其他髓系或实体瘤恶性肿瘤患者的 Navtemadlin 群体药代动力学与药效学分析

了解 CAR-T 细胞疗法动力学的变异性

在暴露-反应分析中使用时间平均暴露指标对二元终点的影响

针对使用瑞德西韦（Vulnerable）治疗的 COVID-19 住院脆弱患者的管理：一项美国医院死亡率回顾性比较效果研究

Collection

Simcyp Publications and Independent Applications

We are proud to share our publications by the Simcyp R&D Team (1997 – Present) and independent applications of Simcyp by industry, academia, and regulatory organizations (2007 – Present).

了解更多信息

All publications

IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia

Modeling and Simulation - QSP, Publication

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

ADC, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, PopPK Modeling and Simulation, Regulatory, Therapeutic Specialties, Publication

MIDD in Japan – Implementations, challenges and opportunities

Drug Development, Modeling and Simulation, Publication

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

Biologics, Certara Products, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Publication

Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores

Modeling and Simulation - QSP, Publication

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. 如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

出版物

Featured publication

IUPHAR review: Computational Psychiatry 2.0. A new tool for supporting combination therapy of psychopharmacology with neuromodulation in schizophrenia

Latest publications

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

MIDD in Japan – Implementations, challenges and opportunities

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

Popular publications